Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

NCT02711007 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

GUO WEI